vs

Side-by-side financial comparison of EPAM Systems (EPAM) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× EPAM Systems). Zimmer Biomet runs the higher net margin — 11.4% vs 7.8%, a 3.7% gap on every dollar of revenue. On growth, EPAM Systems posted the faster year-over-year revenue change (12.8% vs 9.3%). EPAM Systems produced more free cash flow last quarter ($268.1M vs $245.9M). Over the past eight quarters, EPAM Systems's revenue compounded faster (9.9% CAGR vs 3.7%).

EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

EPAM vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.5× larger
ZBH
$2.1B
$1.4B
EPAM
Growing faster (revenue YoY)
EPAM
EPAM
+3.4% gap
EPAM
12.8%
9.3%
ZBH
Higher net margin
ZBH
ZBH
3.7% more per $
ZBH
11.4%
7.8%
EPAM
More free cash flow
EPAM
EPAM
$22.2M more FCF
EPAM
$268.1M
$245.9M
ZBH
Faster 2-yr revenue CAGR
EPAM
EPAM
Annualised
EPAM
9.9%
3.7%
ZBH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EPAM
EPAM
ZBH
ZBH
Revenue
$1.4B
$2.1B
Net Profit
$109.4M
$238.3M
Gross Margin
30.1%
64.6%
Operating Margin
10.6%
17.9%
Net Margin
7.8%
11.4%
Revenue YoY
12.8%
9.3%
Net Profit YoY
5.9%
30.5%
EPS (diluted)
$1.97
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPAM
EPAM
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$1.4B
$2.2B
Q3 25
$1.4B
$2.0B
Q2 25
$1.4B
$2.1B
Q1 25
$1.3B
$1.9B
Q4 24
$1.2B
$2.0B
Q3 24
$1.2B
$1.8B
Q2 24
$1.1B
$1.9B
Net Profit
EPAM
EPAM
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$109.4M
$139.4M
Q3 25
$106.8M
$230.9M
Q2 25
$88.0M
$152.8M
Q1 25
$73.5M
$182.0M
Q4 24
$103.3M
$239.5M
Q3 24
$136.3M
$249.1M
Q2 24
$98.6M
$242.8M
Gross Margin
EPAM
EPAM
ZBH
ZBH
Q1 26
64.6%
Q4 25
30.1%
64.7%
Q3 25
29.5%
72.1%
Q2 25
28.8%
71.5%
Q1 25
26.9%
71.2%
Q4 24
30.4%
71.0%
Q3 24
34.6%
70.5%
Q2 24
29.3%
71.5%
Operating Margin
EPAM
EPAM
ZBH
ZBH
Q1 26
17.9%
Q4 25
10.6%
6.9%
Q3 25
10.4%
17.6%
Q2 25
9.3%
14.4%
Q1 25
7.6%
15.3%
Q4 24
10.9%
19.2%
Q3 24
15.2%
15.3%
Q2 24
10.5%
18.1%
Net Margin
EPAM
EPAM
ZBH
ZBH
Q1 26
11.4%
Q4 25
7.8%
6.2%
Q3 25
7.7%
11.5%
Q2 25
6.5%
7.4%
Q1 25
5.6%
9.5%
Q4 24
8.3%
11.8%
Q3 24
11.7%
13.7%
Q2 24
8.6%
12.5%
EPS (diluted)
EPAM
EPAM
ZBH
ZBH
Q1 26
$1.22
Q4 25
$1.97
$0.71
Q3 25
$1.91
$1.16
Q2 25
$1.56
$0.77
Q1 25
$1.28
$0.91
Q4 24
$1.80
$1.18
Q3 24
$2.37
$1.23
Q2 24
$1.70
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPAM
EPAM
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$1.3B
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$3.7B
$12.7B
Total Assets
$4.9B
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPAM
EPAM
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$1.3B
$591.9M
Q3 25
$1.2B
$1.3B
Q2 25
$1.0B
$556.9M
Q1 25
$1.2B
$1.4B
Q4 24
$1.3B
$525.5M
Q3 24
$2.1B
$569.0M
Q2 24
$1.8B
$420.1M
Total Debt
EPAM
EPAM
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
EPAM
EPAM
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$3.7B
$12.7B
Q3 25
$3.7B
$12.8B
Q2 25
$3.7B
$12.5B
Q1 25
$3.6B
$12.4B
Q4 24
$3.6B
$12.5B
Q3 24
$3.6B
$12.4B
Q2 24
$3.4B
$12.7B
Total Assets
EPAM
EPAM
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$4.9B
$23.1B
Q3 25
$4.8B
$23.5B
Q2 25
$4.7B
$22.9B
Q1 25
$4.7B
$22.2B
Q4 24
$4.8B
$21.4B
Q3 24
$4.5B
$21.7B
Q2 24
$4.2B
$21.5B
Debt / Equity
EPAM
EPAM
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPAM
EPAM
ZBH
ZBH
Operating Cash FlowLast quarter
$282.9M
$359.4M
Free Cash FlowOCF − Capex
$268.1M
$245.9M
FCF MarginFCF / Revenue
19.0%
11.8%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
2.59×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$612.7M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPAM
EPAM
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$282.9M
$517.4M
Q3 25
$294.7M
$418.7M
Q2 25
$53.2M
$378.2M
Q1 25
$24.2M
$382.8M
Q4 24
$130.3M
$506.3M
Q3 24
$242.0M
$395.7M
Q2 24
$57.0M
$369.4M
Free Cash Flow
EPAM
EPAM
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$268.1M
$442.6M
Q3 25
$286.4M
$363.7M
Q2 25
$43.4M
$328.1M
Q1 25
$14.8M
$338.2M
Q4 24
$114.5M
$454.8M
Q3 24
$237.0M
$351.2M
Q2 24
$52.3M
$316.7M
FCF Margin
EPAM
EPAM
ZBH
ZBH
Q1 26
11.8%
Q4 25
19.0%
19.7%
Q3 25
20.5%
18.2%
Q2 25
3.2%
15.8%
Q1 25
1.1%
17.7%
Q4 24
9.2%
22.5%
Q3 24
20.3%
19.3%
Q2 24
4.6%
16.3%
Capex Intensity
EPAM
EPAM
ZBH
ZBH
Q1 26
Q4 25
1.1%
3.3%
Q3 25
0.6%
2.7%
Q2 25
0.7%
2.4%
Q1 25
0.7%
2.3%
Q4 24
1.3%
2.5%
Q3 24
0.4%
2.4%
Q2 24
0.4%
2.7%
Cash Conversion
EPAM
EPAM
ZBH
ZBH
Q1 26
1.51×
Q4 25
2.59×
3.71×
Q3 25
2.76×
1.81×
Q2 25
0.60×
2.48×
Q1 25
0.33×
2.10×
Q4 24
1.26×
2.11×
Q3 24
1.77×
1.59×
Q2 24
0.58×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons